Lauren Haskell
About Lauren Haskell
Lauren Haskell is an Associate Scientist at Bristol Myers Squibb in New Brunswick, New Jersey, with a background in drug discovery and development, and extensive experience in clinical laboratory science and medical technology.
Current Role at Bristol Myers Squibb
Lauren Haskell is currently serving as an Associate Scientist at Bristol Myers Squibb in New Brunswick, New Jersey. In her role, she contributes to research projects primarily focused on drug discovery and development. This position leverages her extensive experience in clinical laboratory science and medical technology, integral for advancing pharmaceutical research.
Previous Experience at Evotec
Lauren Haskell worked at Evotec as a Research Associate from 2019 to 2021 in Princeton, New Jersey. During her tenure, she participated in collaborative research initiatives that significantly enhanced her expertise in drug discovery and development. Her work at Evotec involved various aspects of laboratory research, contributing to her comprehensive understanding of the pharmaceutical industry.
Role at Yoh, A Day & Zimmermann Company
From 2015 to 2019, Lauren Haskell was employed as a Lab Analyst at Yoh, A Day & Zimmermann Company in Swiftwater, PA. In this role, she worked on various laboratory analysis projects. This experience provided her with practical skills and knowledge in laboratory operations and data analysis, which have been fundamental to her career progression in the pharmaceutical field.
Early Career at Pocono Medical Center
Lauren Haskell's career began at Pocono Medical Center, where she served as a Medical Technologist for seven months from 2014 to 2015 in East Stroudsburg. This role allowed her to gain significant experience in medical technology, laying a solid foundation for her subsequent positions in the pharmaceutical industry.
Educational Background
Lauren Haskell obtained a Bachelor's Degree in Clinical Laboratory Science/Medical Technology/Technologist from East Stroudsburg University of Pennsylvania, completing her studies from 2010 to 2014. She furthered her education at Rutgers University, where she earned a Master of Business and Science Degree with a concentration in Drug Discovery and Development. Her academic background supports her expertise and effectiveness in her current and past roles.